China offices will open this year, HHS says
By year's end, the FDA will have three offices opened in China. That's what HHS Secretary Michael Leavitt has pledged, saying that negotiations with the Chinese for clearance to open those FDA branches "have made significant steps forward."
You'll recall that the U.S. and China signed agreements late last year to cooperate more closely on the safety of food, feed, drugs, and medical devices. That was after three very public scandals about Chinese-made ingredients in dog food, toothpaste, and cough medicine. Since then, an even bigger scandal broke--the heparin-contamination problems that have been linked to hundreds of severe allergic reactions and deaths--leading to increased pressure on FDA import safety.
But the wheels of bureaucracy turn slowly, so it's taking months to set up the promised FDA offices in China. One of the reasons, Leavitt says, is that the offices are seen not just as inspections outposts, but as instruments for "a new strategy" on food and drug safety.
- read the Wall Street Journal story
Related Articles:
Bureaucracy slows FDA offices in China
FDA's China office opens next month
FDA moves to allay drug-import fears
FDA Commish chided over import safety
Comments
Ten years late with 5% of the true staffing needs. More smoke & mirrors.
Want to make it happen quicker? No more drug imports without an FDA inspection and certification!
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets

